Identification and characterization of children with asthma-associated comorbidities through computational and immune phenotyping
通过计算和免疫表型分析患有哮喘相关合并症的儿童的识别和特征分析
基本信息
- 批准号:10337267
- 负责人:
- 金额:$ 79.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAlgorithmsAntigensAppendicitisAsthmaAutoimmune DiseasesBirthCD3 AntigensCaregiversCaringCeliac DiseaseCell CycleCenters for Disease Control and Prevention (U.S.)CharacteristicsChildChildhood AsthmaChronic DiseaseClinicClinicalClinical ResearchCohort StudiesCommunicable DiseasesComputerized Medical RecordCountyCross-Sectional StudiesDataDevelopmentDiabetes MellitusDiseaseEarly identificationEnrollmentFamily history ofFutureGoalsHealthHerpes zoster diseaseImmuneImmunityImpairmentInfectionInflammatoryKnowledgeLongitudinal StudiesMeasurementMeasuresMemoryNatural ImmunityNatural Language ProcessingOutcomePatient-Focused OutcomesPatientsPediatric HospitalsPhenotypePneumococcal InfectionsPneumococcal PneumoniaPneumoniaPopulationPopulation SurveillanceRecordsReproducibilityResearchResearch DesignResearch PersonnelRespiratory Tract InfectionsRheumatoid ArthritisRiskRisk FactorsSamplingSioux FallsSiteSubgroupSymptomsT-LymphocyteTimeTime ManagementUnited StatesWorkadaptive immunityasthmaticbasecohortcomorbiditycostempoweredimmunosenescenceimprovedimproved outcomeindexinginhibitormeetingsphenotyping algorithmportabilitypreventpulmonary functionrespiratoryresponsesenescencetool
项目摘要
PROJECT SUMMARY
Asthma, the most common chronic disease among children, is one of the five most burdensome diseases in the
US. While current care and research efforts focus on symptom control and exacerbation risk, children with asthma
may suffer from infectious and inflammatory diseases, ie, asthma-associated infectious and inflammatory disease
comorbidities (AIICs) (eg, pneumococcal disease, herpes zoster, appendicitis, and celiac disease). Although AIICs
pose serious threats to children with asthma, they are largely under-recognized, as evidenced by diabetes mellitus
being widely recognized but a less common chronic illness with a magnitude similar to that for asthma. Presently,
the mechanisms underlying AIICs are unknown. We postulate immunosenescence might be related, as AIICs
coincide with cardinal immunosenescence features. AIICs are not clinically defined and a suitable tool has not been
developed to identify children with AIICs. Thus, no strategies mitigating AIICs risks and outcomes exist.
Addressing these knowledge gaps depends upon two key questions: (1) “How can asthmatic children subgroups
with increased AIICs risk be identified at a population level using electronic medical records?” and (2) “What
immune parameters characterize such children?” Answering these is this proposal's primary goal. To this end, our
current R01 study successfully developed, validated, and implemented natural language processing (NLP)-
empowered computational phenotyping algorithms for two existing criteria for childhood asthma (Predetermined
Asthma Criteria, PAC and Asthma Predictive Index, API). NLP-empowered algorithm application to the 1997-2007
Olmsted County Birth Cohort (OCBC) enabled us to profile a subgroup of children with asthma at increased AIICs
risk, disproportionately represented by children who met both NLP-PAC and NLP-API.
Our new pilot data suggest
asthma potentially accelerates immunosenescence leading to AIICs in a subgroup of asthmatic children.
In this renewal proposal, we target this subgroup who meet both NLP-PAC and NLP-API. We will develop and
apply NLP-empowered computational phenotyping algorithms for AIICs to identify such children at a population
level, then characterize their immune parameters measuring immunosenescence. In Aim 1, we will develop new
NLP-empowered computational phenotyping algorithms for recognized and unrecognized AIICs (NLP-AIIC) for
children enrolled in Mayo Clinic `s 1997-2016 OCBC,
then assess portability of NLP-AIIC at Sanford Children's
Hospital, Sioux Falls, SD
. In Aim 2, we will identify and characterize children with AIICs through new NLP-AIIC and
NLP algorithms for asthma status, by utilizing clinical and immune parameters to measure immunosenescence. In
Aim 3, we will assess changes (eg, waning adaptive immunity) over time in immune parameters measuring
immunosenescence for 300 children in our R01 study, re-enrolling them for further characterization.
This proposed study is indispensable to understanding why some children with asthma develop AIICs, while others
do not. This knowledge will allow us to identify, manage, mitigate, and improve outcomes for AIICs among children.
项目摘要
哮喘是儿童中最常见的慢性疾病,是五种最朴实的疾病之一
我们。尽管当前的护理和研究工作着重于症状控制和加剧风险,但患有哮喘的儿童
可能患有感染性和炎症性疾病,即与哮喘相关的感染性和炎症性疾病
合并症(AIICS)(例如,肺炎球菌疾病,带状疱疹,阑尾炎和腹腔疾病)。虽然aiics
对哮喘儿童构成严重威胁,在很大程度上被低估了,如糖尿病所证明
被广泛认可,但不常见的慢性疾病与哮喘相似。目前,
AIIC的基础机制尚不清楚。我们假设免疫衰老可能是相关的
与基本免疫衰老特征一致。 AIICS没有临床定义,合适的工具没有
开发旨在识别副自力儿童。这是没有策略来减轻AIIC的风险和结果。
解决这些知识差距取决于两个关键问题:(1)“哮喘儿童如何
使用电子病历在人群中确定AIICS风险增加?”和(2)“什么
免疫参数是这种孩子的特征吗?
当前的R01研究成功开发,验证和实施了自然语言处理(NLP) -
赋予两个现有童年哮喘标准的计算表型算法(预定)
哮喘标准,PAC和哮喘预测指数,API)。 NLP授权的算法应用1997-2007
Olmsted County出生队列(OCBC)使我们能够在AIICS中概述一群哮喘子群
风险不成比例地由遇到NLP-PAC和NLP-API的孩子代表。
我们的新试点数据建议
哮喘可能会加速免疫衰老,从而导致哮喘儿童亚组的疾病。
在此续签建议中,我们针对符合NLP-PAC和NLP-API的亚组。我们将发展和
应用NLP授权的计算表型算法,以识别人口的此类儿童
水平,然后表征其免疫过敏。在AIM 1中,我们将开发新的
NLP授权的计算表型算法,用于公认和未识别的AIIC(NLP-aiic)
梅奥诊所的儿童1997-2016 OCBC,
然后评估桑福德儿童的NLP-aiic的可移植性
医院,SIOUX FALLS,SD
。在AIM 2中,我们将通过新的NLP-aiic和
通过使用临床和免疫参数来测量免疫力,NLP的哮喘状态算法。在
AIM 3,我们将随着时间的流逝评估变化(例如,使适应性免疫组织化学减弱)测量
在我们的R01研究中,300名儿童的免疫衰老,重新注册他们以进一步表征。
这项拟议的研究是必不可少的,要理解为什么有些患有哮喘的儿童会发展AIIC,而另一些则是
不要。这些知识将使我们能够识别,管理,减轻和改善儿童副奏的结果。
项目成果
期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification of asthma control factor in clinical notes using a hybrid deep learning model.
- DOI:10.1186/s12911-021-01633-4
- 发表时间:2021-11-09
- 期刊:
- 影响因子:3.5
- 作者:Agnikula Kshatriya BS;Sagheb E;Wi CI;Yoon J;Seol HY;Juhn Y;Sohn S
- 通讯作者:Sohn S
Rural-urban health disparities for mood disorders and obesity in a midwestern community.
- DOI:10.1017/cts.2020.27
- 发表时间:2020-03-24
- 期刊:
- 影响因子:2.6
- 作者:Patten CA;Juhn YJ;Ryu E;Wi CI;King KS;Bublitz JT;Pignolo RJ
- 通讯作者:Pignolo RJ
Assessing health disparities in children using a modified housing-related socioeconomic status measure: a cross-sectional study.
使用修改后的与住房相关的社会经济地位指标评估儿童的健康差异:一项横断面研究。
- DOI:10.1136/bmjopen-2016-011564
- 发表时间:2016
- 期刊:
- 影响因子:2.9
- 作者:Ryu,Euijung;Wi,Chung-Il;Crow,SheriS;Armasu,SebastianM;Wheeler,PhilipH;Sloan,JeffA;Yawn,BarbaraP;Beebe,TimothyJ;Williams,ArthurR;Juhn,YoungJ
- 通讯作者:Juhn,YoungJ
Role of Geographic Risk Factors in COVID-19 Epidemiology: Longitudinal Geospatial Analysis.
- DOI:10.1016/j.mayocpiqo.2021.06.011
- 发表时间:2021-10
- 期刊:
- 影响因子:0
- 作者:Juhn YJ;Wheeler P;Wi CI;Bublitz J;Ryu E;Ristagno EH;Patten C
- 通讯作者:Patten C
Risk, Mechanisms and Implications of Asthma-Associated Infectious and Inflammatory Multimorbidities (AIMs) among Individuals With Asthma: a Systematic Review and a Case Study.
- DOI:10.4168/aair.2021.13.5.697
- 发表时间:2021-09
- 期刊:
- 影响因子:0
- 作者:Kwon JH;Wi CI;Seol HY;Park M;King K;Ryu E;Sohn S;Liu H;Juhn YJ
- 通讯作者:Juhn YJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOUNG J JUHN其他文献
YOUNG J JUHN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOUNG J JUHN', 18)}}的其他基金
Improving the Risk Adjustment Method for Quality Care Measures through Application of an Innovative Individual-Level Socioeconomic Measure
通过应用创新的个人层面的社会经济措施,改进优质护理措施的风险调整方法
- 批准号:
10213256 - 财政年份:2021
- 资助金额:
$ 79.14万 - 项目类别:
Improving the Risk Adjustment Method for Quality Care Measures through Application of an Innovative Individual-Level Socioeconomic Measure
通过应用创新的个人层面的社会经济措施,改进优质护理措施的风险调整方法
- 批准号:
10394328 - 财政年份:2021
- 资助金额:
$ 79.14万 - 项目类别:
Asthma ascertainment and characterization through electronic health records
通过电子健康记录确定和表征哮喘
- 批准号:
9032521 - 财政年份:2015
- 资助金额:
$ 79.14万 - 项目类别:
Enhanced Ascertainment of Asthma Status Via Natural Language Processing
通过自然语言处理增强哮喘状态的确定
- 批准号:
8995191 - 财政年份:2015
- 资助金额:
$ 79.14万 - 项目类别:
Asthma ascertainment and characterization through electronic health records
通过电子健康记录确定和表征哮喘
- 批准号:
8853379 - 财政年份:2015
- 资助金额:
$ 79.14万 - 项目类别:
Enhanced Ascertainment of Asthma Status Via Natural Language Processing
通过自然语言处理增强哮喘状态的确定
- 批准号:
8860691 - 财政年份:2015
- 资助金额:
$ 79.14万 - 项目类别:
Risk of Herpes Zoster Among Adults with Asthma
成人哮喘患者患带状疱疹的风险
- 批准号:
8495928 - 财政年份:2012
- 资助金额:
$ 79.14万 - 项目类别:
Risk of Herpes Zoster Among Adults with Asthma
成人哮喘患者患带状疱疹的风险
- 批准号:
8346055 - 财政年份:2012
- 资助金额:
$ 79.14万 - 项目类别:
Individual Housing Data and Socioeconomic Status
个人住房数据和社会经济状况
- 批准号:
7229827 - 财政年份:2006
- 资助金额:
$ 79.14万 - 项目类别:
Individual Housing Data and Socioeconomic Status
个人住房数据和社会经济状况
- 批准号:
7015211 - 财政年份:2006
- 资助金额:
$ 79.14万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Sleep and Cardiometabolic Subgroup Discovery and Risk Prediction in United States Adolescents and Young Adults: A Multi-Study Multi-Domain Analysis of NHANES and NSRR
美国青少年和年轻人的睡眠和心脏代谢亚组发现和风险预测:NHANES 和 NSRR 的多研究多领域分析
- 批准号:
10639360 - 财政年份:2023
- 资助金额:
$ 79.14万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 79.14万 - 项目类别:
Move and Snooze: Adding insomnia treatment to an exercise program to improve pain outcomes in older adults with knee osteoarthritis
活动和小睡:在锻炼计划中添加失眠治疗,以改善患有膝骨关节炎的老年人的疼痛结果
- 批准号:
10797056 - 财政年份:2023
- 资助金额:
$ 79.14万 - 项目类别:
Mixed methods examination of warning signs within 24 hours of suicide attempt in hospitalized adults
住院成人自杀未遂 24 小时内警告信号的混合方法检查
- 批准号:
10710712 - 财政年份:2023
- 资助金额:
$ 79.14万 - 项目类别: